Guidance for Evolent Health (EVH)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2024 | N/A | N/A | $2.40B – 2.50B | $2.32B | = Maintained | Details |
Q1 2024 | N/A | N/A | $595.00M – 610.00M | $551.00M | = Maintained | Details |
2023 | N/A | N/A | $1.92B – 1.96B | $1.88B | = Maintained | Details |
2023 | N/A | N/A | $1.94B – 1.97B | $1.94B | = Maintained | Details |
2023 | N/A | N/A | $1.95B – 1.97B | $1.95B | = Maintained | Details |
2023 | N/A | N/A | $1.94B – 1.97B | $1.95B | = Maintained | Details |
Q1 2023 | N/A | N/A | $420.00M – 440.00M | $410.10M | = Maintained | Details |
2022 | N/A | N/A | $1.12B – 1.18B | $1.04B | = Maintained | Details |
2022 | N/A | N/A | $1.32B – 1.36B | $1.22B | Raised | Details |
2022 | N/A | N/A | $1.16B – 1.21B | $1.16B | = Maintained | Details |
Q3 2022 | N/A | N/A | $343.00M – 363.00M | $312.70M | Raised | Details |
Q2 2022 | N/A | N/A | $290.00M – 305.00M | $285.00M | = Maintained | Details |
2021 | N/A | N/A | $845.00M – 880.00M | $865.00M | = Maintained | Details |
Q4 2021 | N/A | N/A | $225.00M – 240.00M | $227.20M | = Maintained | Details |
Q2 2021 | N/A | N/A | $210.00M – 225.00M | $212.00M | = Maintained | Details |
2020 | N/A | N/A | $935.00M – 985.00M | $963.80M | = Maintained | Details |
2020 | N/A | N/A | $935.00M – 985.00M | $935.79M | = Maintained | Details |
2020 | N/A | N/A | $995.00M – 1035.00M | $977.90M | = Maintained | Details |
Q4 2020 | N/A | N/A | $249.00M – 264.00M | $266.60M | = Maintained | Details |
Q3 2020 | N/A | N/A | $258.00M – 272.00M | $242.00M | = Maintained | Details |
Q2 2020 | N/A | N/A | $236.00M – 247.00M | $240.30M | = Maintained | Details |
Q1 2020 | N/A | N/A | $233.50M – 245.50M | $234.76M | = Maintained | Details |
2019 | N/A | N/A | $825.00M – 850.00M | $840.71M | = Maintained | Details |
2019 | N/A | N/A | $805.00M – 880.00M | $849.83M | = Maintained | Details |
Q4 2019 | N/A | N/A | $227.50M – 239.50M | $229.30M | = Maintained | Details |
Q3 2019 | N/A | N/A | $213.50M – 225.50M | $213.51M | = Maintained | Details |
Q2 2019 | N/A | N/A | $187.00M – 195.00M | $193.90M | = Maintained | Details |
Q1 2019 | N/A | N/A | $188.00M – 197.00M | $205.02M | = Maintained | Details |
2018 | N/A | N/A | $565.00M – 585.00M | $600.39M | = Maintained | Details |
Q4 2018 | N/A | N/A | $167.00M – 171.00M | $152.22M | Raised | Details |
Q3 2018 | N/A | N/A | $570.00M – 585.00M | N/A | = Maintained | Details |
Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2016 | N/A | N/A | $212.00M – 220.00M | N/A | = Maintained | Details |
2016 | N/A | N/A | $224.00M – 226.00M | $221.30M | = Maintained | Details |
Q2 2016 | N/A | N/A | $51.00M – 52.00M | N/A | = Maintained | Details |
2015 | N/A | N/A | $159.00M – 161.00M | N/A | = Maintained | Details |
Q3 2015 | N/A | N/A | $42.00M – 43.00M | N/A | = Maintained | Details |